Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors

BACKGROUND: Chimeric antigen receptor T (CAR-T) cell therapy has made significant advances for hematological malignancies but encounters obstacles in the treatment of solid tumors mainly due to tumor immunosuppressive microenvironment. METHODS: Immunohistochemistry analysis was performed to examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fanfan, Zhao, Shuping, Wei, Cheng, Hu, Yaodi, Xu, Tianlong, Xin, Xueyi, Zhu, Tingwei, Shang, Liting, Ke, Shanwen, Zhou, Jiang, Xu, Xiaojun, Gao, Yue, Zhao, Ai, Gao, Jimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720259/
https://www.ncbi.nlm.nih.gov/pubmed/36479116
http://dx.doi.org/10.3389/fimmu.2022.958082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720259/
https://www.ncbi.nlm.nih.gov/pubmed/36479116
http://dx.doi.org/10.3389/fimmu.2022.958082

Ejemplares similares